Valuation: IRRAS AB (publ)

Market Cap 182M 18.69M 16.39M 15.11M 14.14M 26.5M 1.76B 27.07M 70.29M 869M 70.18M 68.64M 3.04B P/E 2023
-0.73x
P/E 2024 -1.89x
Enterprise Value 396M 40.67M 35.68M 32.89M 30.78M 57.68M 3.84B 58.91M 153M 1.89B 153M 149M 6.62B EV / Sales 2023
5.26x
EV / Sales 2024 6.82x
Free-Float
3.55%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 51 2021-06-30
Director of Finance/CFO 40 2021-06-16
Investor Relations Contact - 2021-03-08
Director TitleAgeSince
Director/Board Member 68 2015-05-31
Chairman 53 2020-08-17
Director/Board Member 71 2017-08-31
Change 5-day change 1-year change 3-year change Capi.($)
-3.63%-70.75% - - 16.9M
+5.25%+8.09%-15.17%+11.69% 121B
-0.65%+0.53%+3.83%-7.89% 12.85B
+1.30%+10.51%+45.42%+114.05% 8.37B
-3.88%-6.41%-50.89%-72.88% 3.95B
-0.38%-0.97%+16.76%+37.20% 2.53B
-9.06%+10.10%+218.77%+159.71% 1.7B
-8.75%-13.25%-27.64%-24.60% 1.68B
-2.80%-3.48%-2.92%-23.20% 1.57B
Average -2.51%-0.90%+23.52%+24.26% 19.23B
Weighted average by Cap. +3.82%+2.40%-8.11%+14.76%

Financials

2023 2024
Net sales 42.88M 4.41M 3.87M 3.57M 3.34M 6.25M 416M 6.39M 16.58M 205M 16.56M 16.19M 718M 57.98M 5.96M 5.23M 4.82M 4.51M 8.46M 562M 8.64M 22.43M 277M 22.39M 21.9M 971M
Net income -209M -21.48M -18.84M -17.37M -16.25M -30.46M -2.03B -31.11M -80.79M -999M -80.65M -78.88M -3.5B -95.98M -9.87M -8.66M -7.98M -7.47M -14M -931M -14.29M -37.12M -459M -37.06M -36.25M -1.61B
Net Debt 43.85M 4.51M 3.96M 3.65M 3.41M 6.39M 425M 6.53M 16.96M 210M 16.93M 16.56M 734M 214M 21.98M 19.28M 17.78M 16.64M 31.17M 2.07B 31.84M 82.69M 1.02B 82.55M 80.74M 3.58B
Logo IRRAS AB (publ)
Irras AB is Sweden- based medical device company primarily engaged in develops and commercializes solutions that are designed to transform neurocritical care. Company focus on neurosurgical procedures, where excess cerebrospinal fluid (CSF) or toxic blood byproducts often need to be emergently drained and intracranial pressure (ICP) needs to be closely regulated.
Employees
43